News

The program to facilitate engagement between HCPs, industry, and regulatory bodies.

Deal aims to provide diabetes treatment to patients across the continent.

SaaS’ branded platform expected to help grow manufacturer’s therapeutic development processes.

CDMO will continue to produce commercial antibody cancer drug substance, featuring a new $242 million agreement.

The draft guidance document discusses the development of labeling for proposed biosimilars and interchangeable biosimilars for submission under section 351(k) of the Public Health Service Act.

PBM transparency and data reporting requirements are likely to be part of a larger healthcare bill that Congress will work on this fall.

Protective case manufacturer hires James Curleigh, as company prepares to further innovation and expand.

Appointment comes amid resignation of Marie-France Tschudin from company executive committee.

Collaboration aims to expedite the transportation of cancer detection radiopharmaceuticals throughout Chile.

Further expansions of the pharmaceutical development and manufacturing services of ten23 are happening at the BASE and VIVA facilities to continue to support complex sterile product development, testing, and manufacturing.

Organization hires Kala Shankle, who joins the team with supply chain security and drug pricing experience.

IATA statistics suggest improvement over recent months.

Novo Nordisk receives the full rights to develop and commercialize the lead program.

Pharma Commerce provides a synopsis of the presentation.

Biopharma company now required to seek approval before attempting further buyouts.

Shift comes with $5 million dedication to launch Cencora’s healthier futures grant program.

Alexion – AstraZeneca Rare Disease, GSK, Novartis, Pfrizer, and Zoetis will join the newly established life sciences platform.

Delay to allow agency to consider other ways of solving the issue, filing says.

The latest people news happenings over the past month.

Collaboration to focus on digital therapeutics.

After concerns raised by multiple supply chain participants over readiness, the agency steps back.

Program designed to aid life science organizations in improving go-to-market strategy.

Expansion allows facility to provide E2E services in one location, including commercial manufacturing.

The deal helps the logistics provider—who operates in the healthcare space—continue to grow its services.

Program’s goal is to maximize aviation industry’s contribution to development across the African continent.

Abrysvo is allowed to be given to individuals who are 32-36 weeks pregnant.

Acquisition expands 3PL’s presence in India, adds 7.7 million square feet of facility space.